Marketing

About Marketing

This author has not yet filled in any details.
So far Marketing has created 93 blog entries.

MMIS President and CEO Michaeline Daboul to Speak at 17th Annual Pharmaceutical and Medical Device Compliance Congress

Leveraging Enterprise Analytics for Compliance Monitoring

Portsmouth, NH, October 13, 2016 – MMIS, creator of the award winning MediSpend Global Compliance Platform, announced today that President and CEO Michaeline Daboul will join legal and compliance experts at the 17th Annual Pharmaceutical and Medical Device Compliance Congress to be held on October 19-21, 2016 in Washington, DC. 

Ms. […]

MMIS President and CEO Michaeline Daboul to speak at CBI’s 10th Annual Forum on Transparency & Aggregate Spend

Insight and Predictions: Shedding Light on the Future Use of Open Payments Data

Washington, DC, August 15, 2016 – MMIS, Inc. creator of the award winning MediSpend Global Compliance Platform, announced today that MMIS President and CEO, Michaeline Daboul, will join legal and compliance professionals from CMS, EFPIA, Johnson & Johnson, and AstraZeneca […]

MMIS to Sponsor 13th Annual Pharmaceutical Compliance Congress

Award Winning MediSpend® Global Compliance Platform to be Showcased at World’s Largest Compliance Event for the Bio/pharmaceutical Industry

New York, NY, April 22, 2016 – MMIS, the company behind MediSpend® Global Compliance Platform, the leading global compliance and transparency solution for the life sciences industry, will be a sponsor at the 13th Annual […]

MediSpend Recognized as Top Pharma and Life Sciences Technology Solution Provider for Second Consecutive Year

Company’s Global SaaS Compliance Platform Helps Customers Meet Transparency Requirements Through Innovation and Technology Leadership

Portsmouth, NH, April 19, 2016 – MMIS, creator of the MediSpend Global Compliance Platform, the industry standard compliance and transparency solution for the life sciences industry, today announced it has been selected by CIOReview for its 2016 listing […]

MMIS Sponsors 4th Annual Conference on Corporate Compliance and Transparency in the Pharmaceutical Industry

Company to Discuss Best Practices for Implementing an Effective Global Compliance Monitoring and Risk Assessment Program

Portsmouth, NH, February 24, 2016 – MMIS, creator of the MediSpend® Global Compliance Platform, the leading global compliance and transparency solution for the life sciences industry, today announced it is a sponsor of the Corporate Compliance […]

Legislative Alert – CMS Annual Report Fiscal Year 2014 – Summary

On April 26 2015, the Centers for Medicare and Medicaid Services (CMS) submitted its annual report to Congress on the Open Payments Program for fiscal year 2014 as required by 42 U.S.C. 1320a-7h(d)(1). The following MediSpend® Legislative Alert will summarize the salient points of the annual report along with legislative updates related to the Open […]

MediSpend Global Compliance Technology Platform Recognized as Top Solution

Top 20 Most Promising Pharma and Life Science Technology Solution Provider for 2015

Portsmouth, NH, April 17, 2015 – CIO Review (www.cioreview.com) has chosen MMIS (medispend0.wpengine.com) for its 20 Most Promising Pharma and Life Science Technology Solution Providers 2015. The positioning is based on MMIS’s MediSpend global compliance technology platform for life sciences companies.

The annual list […]

MMIS Partners with Healthcare Data Solutions to Deliver New, Cost-Effective Aggregate Spend Technology

MMIS and Healthcare Data Solutions (HDS) partner to bring a new spend tracking compliance solution paired with compliance-grade data specifically tailored to support small and medium-sized life sciences companies in complying with Open Payments requirements.

Portsmouth, NH, March 17, 2015 – MMIS, creator of The MediSpend®Global Compliance Platform, the leading global compliance and transparency solution for […]

Open Payments: New Technology Solution Launched

Portsmouth, NH, November 5, 2014 – MMIS, creator of The MediSpend® Global Compliance Platform, the leading global compliance and transparency solution for the life sciences industry, today announced a new solution, MediSpend Federal to support small to mid-size companies in the life sciences industry.

Manufacturers who have hundreds instead of thousands of annual spend transactions, want a robust, rules-based federal reporting system that will produce all required federal Open Payments (Sunshine Act) reports. MediSpend Federal brings an affordable, easy to implement SaaS platform that validates and verifies HCPs and HCOs upon data import and ensures accurate and timely reporting for small to mid-sized life sciences companies.

Highlights from First Open Payments Data Set

Yesterday, CMS made the first round of Open Payment data sets publically available on its website. The goal of collecting and making the information available is to help everyone understand the relationship between the healthcare industry (e.g., pharmaceutical and medical device manufactures) and healthcare providers (such as physicians and teaching hospitals).

The data released […]